The global market for micro servers is observing massive call for competent computing goods, which has obliged market players to upturn their concentration on product invention and development of the current assortment. Mergers, acquisit…
BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinational
drugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size and
its reliance on out-of-pocket payments highlight the challenges it poses. Moreover, continued economic
weakness and negative demographic trends will limit growth prospects.
Headline Expenditure Projections
? Pharmaceuticals: MDL5.83bn (USD310mn) in 2015 to MDL6.23bn (USD322mn) in 2016; 6.7% in
local currency terms and 3.8% in US dollar terms. Forecast unchanged from previous quarter.
? Healthcare: MDL12.32bn (USD654mn) in 2015 to MDL13.27bn (USD686mn) in 2015; +7.7% in local
currency terms and 4.8% in US dollar terms. Forecast unchanged from previous quarter.